Adana City Hospital Researcher Adds New Findings in the Area of Chronic Myeloid Leukemia (One Case of Chronic Myeloid Leukemia in Pediatric Group).

A recent study conducted at Adana City Hospital focused on chronic myeloid leukemia (CML) in the pediatric population, a rare form of leukemia in children and adolescents. The study highlighted a case of a 14-year-old male with CML, showcasing symptoms such as abdominal distension, bone pain, and weakness. Treatment involved Imatinib therapy, a first-line drug for CML, which resulted in a significant reduction in the BCR-ABL1 fusion transcript levels. This research sheds light on the importance of specific therapies like Imatinib in managing CML in pediatric patients. [Extracted from the article]